Antineoplastic Agents Drug Interactions of Clinical Significance
- 1 March 1995
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 12 (3) , 168-182
- https://doi.org/10.2165/00002018-199512030-00003
Abstract
With the use of numerous drugs in the treatment of cancer, the potential for drug interactions is considerable. Because of the limited therapeutic indices of anticancer drugs, one should be aware...Keywords
This publication has 96 references indexed in Scilit:
- Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemiaThe Journal of Pediatrics, 1990
- Interaction of Etretinate with Methotrexate Pharmacokinetics in Psoriatic PatientsThe Journal of Clinical Pharmacology, 1990
- Life threatening interaction between tamoxifen and warfarin.BMJ, 1989
- Clinical Pharmacokinetics of DoxorubicinClinical Pharmacokinetics, 1988
- Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin a phase I-II studyCancer, 1987
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986
- Interaction of cyclosporin A with antineoplastic agentsJournal of Molecular Medicine, 1985
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and adriamycinCancer, 1976
- Qualitative and quantitative defects of pseudocholinesterase activityAnaesthesia, 1967